NCT02854800 - Smoking Cessation & Opioid Dependence Treatment Integration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2016

Primary Completion Date

April 10, 2017

Study Completion Date

April 10, 2017

Conditions

Smoking CessationOpioid Related Disorders

Interventions

DRUG

varenicline

Participants followed the schedule of dosing that is specified on the label: 0.5 mg once daily (Days 1-3), 0.5 mg twice daily (Days 4-7), and 1 mg twice daily (Days 8-84).

Trial Locations (1)

26505

West Virginia University Chestnut Ridge Center, Morgantown